ElevateBio Chief Technology Officer Michael Paglia developed a 10-question framework for choosing a CDMO based on his experience leading process development and manufacturing teams.
Published
Signal category
Research & Knowledge
Quote
“Our Chief Technology Officer Michael Paglia has developed a 10-question framework for choosing your next CDMO”
— ElevateBio team
Company
- Industry
- Pharmaceutical Manufacturing
- Location
- Waltham, US
- Company size
- 450 employees
ElevateBio is a technology-driven advanced therapy contract development and manufacturing organization (CDMO) powering the creation of life-transforming therapies. The company helps biopharmaceutical partners design, develop, and manufacture therapies from early discovery through commercialization. Combining proprietary gene editing tools and services, cGMP manufacturing capabilities, and industry-leading expertise, ElevateBio is enabling partners advance a breadth of therapeutic approaches and modalities including cell therapies, gene edited therapies, RNA therapies, mRNA vaccines, and more.